يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Metalloproteinase and disintegrin"', وقت الاستعلام: 0.37s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Revista Colombiana de Biotecnología; Vol. 21 Núm. 1 (2019); 29-38 ; Revista Colombiana de Biotecnología; Vol. 21 No. 1 (2019); 29-38 ; 1909-8758 ; 0123-3475

    وصف الملف: application/pdf; application/xml

    Relation: https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/pdf; https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/71938; Baragaño, A., Martín-Palanco, V., Fernandez, A.F., et al. (2015). Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Genes Immun. 16(1):71-82.; Barry, M., & Bleackley, R.C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2: 401-409.; Boutet, P., Agüera, S., Atkinson, S., et al. (2009). Cutting Edge: The Metalloproteinase ADAM17/ TNF- α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein. J. Immunol. 182: 49-53.; Chen, J.R., Lee, Y.J., Chen, T., et al. (2005). MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer. Neoplasma. 52:369-73; Chen, D., Juko-Pecirep, I., Hammer, J., et al. (2013). Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst. 105:624-33; Chitadze, G., Bhat, J., Lettau, M., et al. (2013). Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications. Scand. J. Immunol. 78:120-129.; Choy, M.K, & Phipps, M.E. (2010). MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 16: 97-106.; de Kruijf, E.M., Sajet, A., van Nes, J.G., et al. (2012). NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. BMC Cancer. 12:24; Del Toro, S., Arreygue, N., Aguilar, A., et al. (2011). MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines. Cancer Cell Int. 11:15; Doubrovina, E., Doubrovin, M., Vider, E., et al. (2003). Evasion from NK Cell Immunity by MHC Class I Chain- Related Molecules Expressing Colon Adenocarcinoma. J. Immunol. 171: 6891-6899; Eagle, RA., Traherne, J.A., Hair, JR., et al. (2009). ULBP6/RAET1L is an additional human NKG2D ligand. Eur. J. Immunol. 39: 3207–3216; GLOBOCAN 2012: Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 http://globocan.iarc.fr/Pages/fact_sheets_population.aspx; Huergo-Zapico, L., Acebes-Huerta, A., López-Soto, A., et al. (2014). Molecular Bases for the Regulation of NKG2D Ligands in Cancer. Front Immunol. 21;5:106.; Jiménez, M.I., Suarez, L.F., Ortiz, PC., et al. (2012). Cervical cancer cell lines expressing NKG2D ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology, 13(7): 1-10.; Jung, Y.S., Najy, A.J., Huang, W., et al. (2017). HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget. 8:51530-51541.; Lieberman, J. (2003). The ABCs of granule-mediated cytotoxicity: new weapons inthe arsenal. Nat Rev Immunol 3: 361-370.; McCarthy, M.T., Moncayo, G., Hiron, T.K., et al. (2018). Purine nucleotide metabolism regulates expression of the human immune ligand MICA. J Biol Chem. 293:3913-24.; Mendoza J.F. (2007). Los genes mica y micb: su polimorfismo e importancia biológica. VERTIENTES Rev Esp en Ciencias de la Salud, 10:3-7.; Obeidy, P., & Sharland, A.F. (2009). NKG2D and its ligands. Int J Biochem Cell Biol. 41(12):2364-7.; Pende, D., Rivera, P., Marcenaro, S., et al. (2002). Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62(21):6178-86.; Pffafl, M.W. (2001). A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acids Research. (9):1-6.; Salih, H., Rammensee, H., Steinle, A. (2002). Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding. J. Immunol. 169:4098-4102.; Sheu, B., Lien, H., Ho, H., et al. (2003). Increased Expression and Activation of Gelatinolytic Matrix Metalloproteinases Is Associated with the Progression and Recurrence of Human Cervical Cancer. Cancer Res. 63: 6537-6542.; Textor, S., Durst, M., Jansen, L., et al. (2008). Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int. J. Cancer 123: 2343-2353.; Vivier, E., Raulet, D.H., Moretta, A., et al. (2011). Innate or adaptive immunity? The example of natural killer cells. Science. 331 (6013): 44-9.; Waldhauer, I., Goehlsdorf, D., Gieseke, F., et al. (2008). Tumor-Associated MICA is Shed by ADAM Proteases. Cancer Res. 68: 6368-6376.; Xu, Q., Ying, M., Chen, G., et al. (2013). ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. Tumor Biol. 35(8):7575-86.; Yun, JJ., Heisler, LE., Hwang, IL., et al. (2006). ADN genómico funciona como un estándar universal externa cuantitativa en tiempo real PCR. Nucleic Acids Research. 34(12):e85.; https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730

  2. 2

    المصدر: Revista Colombiana de Biotecnología, Volume: 21, Issue: 1, Pages: 29-38, Published: JUN 2019
    Revista Colombiana de Biotecnología, Vol 21, Iss 1 (2019)

    وصف الملف: text/html

  3. 3
    Academic Journal
  4. 4
    Electronic Resource

    Additional Titles: Expresión génica de ligandos mica, micb y ulbp (1-6) del receptor NKG2D de células natural killer y metaloproteinasas adam10, adam17 y mmp14 en lineas celulares de cancer de cervical

    المصدر: Revista Colombiana de Biotecnología; Vol. 21 Núm. 1 (2019); 29-38; Revista Colombiana de Biotecnología; Vol. 21 No. 1 (2019); 29-38; 1909-8758; 0123-3475

    URL: https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/pdf
    https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/71938
    https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/pdf
    https://revistas.unal.edu.co/index.php/biotecnologia/article/view/79730/71938
    *ref*/Baragaño, A., Martín-Palanco, V., Fernandez, A.F., et al. (2015). Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Genes Immun. 16(1):71-82.
    *ref*/Barry, M., & Bleackley, R.C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2: 401-409.
    *ref*/Boutet, P., Agüera, S., Atkinson, S., et al. (2009). Cutting Edge: The Metalloproteinase ADAM17/ TNF- α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein. J. Immunol. 182: 49-53.
    *ref*/Chen, J.R., Lee, Y.J., Chen, T., et al. (2005). MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer. Neoplasma. 52:369-73
    *ref*/Chen, D., Juko-Pecirep, I., Hammer, J., et al. (2013). Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst. 105:624-33
    *ref*/Chitadze, G., Bhat, J., Lettau, M., et al. (2013). Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications. Scand. J. Immunol. 78:120-129.
    *ref*/Choy, M.K, & Phipps, M.E. (2010). MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 16: 97-106.
    *ref*/de Kruijf, E.M., Sajet, A., van Nes, J.G., et al. (2012). NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. BMC Cancer. 12:24
    *ref*/Del Toro, S., Arreygue, N., Aguilar, A., et al. (2011). MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines. Cancer Cell Int. 11:15
    *ref*/Doubrovina, E., Doubrovin, M., Vider, E., et al. (2003). Evasion from NK Cell Immunity by MHC Class I Chain- Related Molecules Expressing Colon Adenocarcinoma. J. Immunol. 171: 6891-6899
    *ref*/Eagle, RA., Traherne, J.A., Hair, JR., et al. (2009). ULBP6/RAET1L is an additional human NKG2D ligand. Eur. J. Immunol. 39: 3207–3216
    *ref*/GLOBOCAN 2012: Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
    *ref*/Huergo-Zapico, L., Acebes-Huerta, A., López-Soto, A., et al. (2014). Molecular Bases for the Regulation of NKG2D Ligands in Cancer. Front Immunol. 21;5:106.
    *ref*/Jiménez, M.I., Suarez, L.F., Ortiz, PC., et al. (2012). Cervical cancer cell lines expressing NKG2D ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology, 13(7): 1-10.
    *ref*/Jung, Y.S., Najy, A.J., Huang, W., et al. (2017). HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget. 8:51530-51541.
    *ref*/Lieberman, J. (2003). The ABCs of granule-mediated cytotoxicity: new weapons inthe arsenal. Nat Rev Immunol 3: 361-370.
    *ref*/McCarthy, M.T., Moncayo, G., Hiron, T.K., et al. (2018). Purine nucleotide metabolism regulates expression of the human immune ligand MICA. J Biol Chem. 293:3913-24.
    *ref*/Mendoza J.F. (2007). Los genes mica y micb: su polimorfismo e importancia biológica. VERTIENTES Rev Esp en Ciencias de la Salud, 10:3-7.
    *ref*/Obeidy, P., & Sharland, A.F. (2009). NKG2D and its ligands. Int J Biochem Cell Biol. 41(12):2364-7.
    *ref*/Pende, D., Rivera, P., Marcenaro, S., et al. (2002). Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62(21):6178-86.
    *ref*/Pffafl, M.W. (2001). A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acids Research. (9):1-6.
    *ref*/Salih, H., Rammensee, H., Steinle, A. (2002). Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding. J. Immunol. 169:4098-4102.
    *ref*/Sheu, B., Lien, H., Ho, H., et al. (2003). Increased Expression and Activation of Gelatinolytic Matrix Metalloproteinases Is Associated with the Progression and Recurrence of Human Cervical Cancer. Cancer Res. 63: 6537-6542.
    *ref*/Textor, S., Durst, M., Jansen, L., et al. (2008). Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int. J. Cancer 123: 2343-2353.
    *ref*/Vivier, E., Raulet, D.H., Moretta, A., et al. (2011). Innate or adaptive immunity? The example of natural killer cells. Science. 331 (6013): 44-9.
    *ref*/Waldhauer, I., Goehlsdorf, D., Gieseke, F., et al. (2008). Tumor-Associated MICA is Shed by ADAM Proteases. Cancer Res. 68: 6368-6376.
    *ref*/Xu, Q., Ying, M., Chen, G., et al. (2013). ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. Tumor Biol. 35(8):7575-86.
    *ref*/Yun, JJ., Heisler, LE., Hwang, IL., et al. (2006). ADN genómico funciona como un estándar universal externa cuantitativa en tiempo real PCR. Nucleic Acids Research. 34(12):e85.